Scientific Library
New cancer treatment may reawaken the immune system
Cancer is a disease caused by abnormal cell growth. The cells’ genetic material is corrupted and the metabolic processes do not interact well with them anymore. They grow unchecked, mostly in the form
What is the future of mRNA based therapeutics, and their main challenges?
mRNA is a ribonucleic acid used by cells as an intermediate carrier of the genetic information contained in the DNA to synthesize proteins, and corresponds to the copy of one of the two strands of DNA.
Unlocking the Power of Immuno-Oncology: Cutting-Edge Tools for Cancer Research
Access an exciting on-demand webinar where we dive into the latest therapeutic strategies leveraging the immune system to combat cancer, with a focus on
Elevate Your Proteomic Research with Tebubio’s Biomarker & Biostatistics Expertise
Access an engaging on-demand webinar to discover how our Europe-based Contract Research Service Laboratory Platform, led by a team of expert scientists and biostatisticians, can help you overcome challenges
Biological samples solutions: the chalenges of in vitro models
Access this on-demand webinar to discover how Tebubio leverages its expertise to help you source high-quality human biological samples, enabling you to develop the in-vitro model best suited to your research
Accelerate your mRNA-based proof-of-concepts studies with Tebubio
Watch this on-demand webinar to learn how Tebubio's Contract Research Service laboratory and experts can help you overcome the key challenges in developing innovative mRNA-based therapies.
Assessing Cellular PARylation: Convenient ELISA-Based Methods
Discover how ELISA-based methods enable precise PARylation assessment in intact cells. Learn about the role of PARP and PARG inhibitors in drug discovery and cancer research.
Explore commercial kits for
LIVE-Stepâ„¢ Cell Assay System: A Next-Generation Solution for Measuring Cell Viability
Discover the LIVE-Stepâ„¢ Cell Assay System: a fast, sensitive, and cost-effective solution for measuring cell viability in drug screening, cancer research, and toxicity studies.
Learn how this ATP-based
How to Identify Efficient LNP Formulations for Your Model? Insights from Tebubio's Delivery Platform
Access an engaging on-demand webinar to discover how our Europe-based Contract Research Service Laboratory can help you screen the most effective LNP formulations for optimal RNA delivery into your cell
Development and Imaging Validation of Fluorescent Lipid Nanoparticles for RNA Delivery Applicable to Personalized In Vitro Oncology Models
Discover how Tebubio's innovative LNP platform enables real-time tracking of RNA delivery in oncology models. Explore our latest findings and applications for personalized medicine.
Bispecific Antibodies: A Revolution in Cancer Treatment
In this blog, we will delve into how BITE antibodies, are transforming cancer treatment strategies, with a special focus on the tools developed by our partner, BPS Biosciences, to help you develop and
Gamma Delta T Cells : A promising Avenue for Novel Cancer Immunotherapies
In this blog, we delve into the potential of Gamma Delta (γδ) T cells in the development of new cancer treatment, and how thanks to the tools developed by our partner BPS Bioscience we can support you